Results 11 - 20 of 32 : Previous 1 2 3 4 Next
Soliris Brightens Alexion's Quarter
The pharmaceutical's lone drug posts gargantuan growth.
Will These Drugs Get FDA Approval?
Heads up, drug company investors.
These companies are buying back their shares. Should you join them?
Progenics' Double Dose of Good News
Its lead drug gets FDA approval and a positive EU recommendation.
Wyeth Recovers From Its Heartburn
Wyeth deals with generic competition for one of its biggest drugs.
Smart investors who achieve outsized profits: See what the best CAPS players recommend now.
Its drug to help patients after abdominal surgery fails in its phase 3 trial.
Wednesday's Worst Stocks in the World
It had to be someone.
Adolor Advisory Panel Aftermath
An FDA advisory panel votes favorably on Adolor's lead drug.
Adolor Under the FDA's Spotlight
The FDA releases its documents on Adolor's lead drug.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK